NVS
Novartis AG
NYSE · Healthcare · Drug Manufacturers - General · CH
$159.68
−2.09%Institutional positioning
13F filings over the trailing two quarters
New 333Increased 1071Reduced 1138Sold out 90
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Fisher Asset Management, LLC | Increased | 15,523,378 | Aug 4, 2026 |
| FISHER ASSET MANAGEMENT, LLC | Increased | 13,885,749 | May 5, 2026 |
| MORGAN STANLEY | Increased | 8,726,827 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 8,527,037 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 8,117,586 | Aug 11, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 8,110,116 | May 7, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 7,567,354 | May 11, 2026 |
| DODGE & COX | Reduced | 6,967,383 | May 14, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 6,592,124 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 6,525,771 | May 15, 2026 |
| LOOMIS SAYLES & CO L P | Reduced | 5,426,100 | May 14, 2026 |
| LOOMIS SAYLES & CO L P | Reduced | 5,239,309 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 4,962,794 | May 18, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 4,909,938 | Aug 14, 2026 |
| FRANKLIN RESOURCES INC | Reduced | 3,409,944 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings